Publication | Open Access
Survival Trends in Sorafenib for Advanced Hepatocellular Carcinoma: A Reconstructed Individual Patient Data Meta-Analysis of Randomized Trials
18
Citations
46
References
2023
Year
Survival outcomes for sorafenib in advanced HCC have improved over time. These data have important implications for clinical trial design.
| Year | Citations | |
|---|---|---|
Page 1
Page 1